Infinity Pharma (INFI) Tops Q3 EPS by 47c

November 9, 2016 4:49 PM EST
Get Alerts INFI Hot Sheet
Trade INFI Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Infinity Pharma (NASDAQ: INFI) reported Q3 EPS of ($0.39), $0.47 better than the analyst estimate of ($0.86).

At September, 2016, Infinity had total cash, cash equivalents and available-for-sale securities of $112.3 million, compared to $146.4 million at June 30, 2016.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment